Back to Search
DOMINICK CARBONE, MD
MD
Urology Physician
NPI: 1790767382IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
9700498(NC)
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 1990
Research & Publications (20)
Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nitric-oxide synthase 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.
PMID 18840677·Mol Pharmacol·2009
7-preclinical
Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP.
PMID 18508038·Brain Res·2008
7-preclinical
Versatile vacuum chamber for in situ surface X-ray scattering studies.
PMID 18552436·J Synchrotron Radiat·2008
8-other
Treatment of gay men for post-traumatic stress disorder resulting from social ostracism and ridicule: cognitive behavior therapy and eye movement desensitization and reprocessing approaches.
PMID 17674178·Arch Sex Behav·2008
5-case
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.
PMID 15983396·J Clin Oncol·2005
3-trial
Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease.
PMID 15951401·J Pharmacol Exp Ther·2005
7-preclinical
Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
PMID 16097806·Chem Res Toxicol·2005
7-preclinical
Biomarkers of response to gefitinib in non-small-cell lung cancer.
PMID 16264818·Nat Clin Pract Oncol·2004
8-other
Lung cancer: early events, early interventions: conference summary for the 46th Annual Thomas L Petty Aspen Lung Conference.
PMID 15136492·Chest·2004
8-other
Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal.
PMID 15540944·Chem Res Toxicol·2004
7-preclinical
4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase.
PMID 15454282·Free Radic Biol Med·2004
7-preclinical
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
PMID 19493905·Carcinogenesis·2009
7-preclinical
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.
PMID 19276291·Clin Cancer Res·2009
3-trial
X-ray structure analysis of free-standing lipid membranes facilitated by micromachined apertures.
PMID 18370435·Langmuir·2008
8-other
Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways.
PMID 18335517·J Neurosci Res·2008
7-preclinical
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
PMID 18349398·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 JOHNSON RIDGE MEDICAL PARK
ELKIN, NC 28621 - Phone
- (336) 526-0040
Quick Facts
- NPI
- 1790767382
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile